navtemadlin
kartos therapeutics
['krt-232', 'melanoma']
great discussion of three very interesting abstracts to end the melanoma/skin oral session #asco22 by my colleague and mentor . good points re: toxicity profile of krt-232 in elderly, often frail mcc patients. 
Med onc at UW/SCCA/Fred Hutch focused on melanoma and RCC, interested in patient/caregiver QOL and all things immunotherapy. All opinions are my own.